Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01726200
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AXL | 2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)- ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | B | 1LL9 | 0.87 | |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.73 | |
CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.72 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.73 | |
ARY | ARYLOMYCIN A2 | A,B | 1T7D | 0.75 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | A | 2Q63 | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | B | 2Q64 | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | B,D | 2R5Q | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | A | 2PYN | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | A | 2QAK | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | A | 2PYM | 0.72 | |
1UN | 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL SULFANYL- BUTYL]-DECAHYDRO-ISOQUINOLINE-3- CARBOXYLIC ACID TERT-BUTYLAMIDE | A | 1OHR | 0.72 | |
C1N | N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~- [3-FLUORO-1-(4-HYDROXYBENZYL)-2- OXOPROPYL]LEUCINAMIDE | A | 1ZCM | 0.71 | |
1C5 | [[O-PHOSPHONO-N-ACETYL-TYROSINYL]- GLUTAMYL-3[CYCLOHEXYLMETHYL]ALANINYL]- AMINE | A | 1BKM | 0.71 | |
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A,B,C,D | 2ZMW | 0.76 | |
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A | 2ZMU | 0.76 | |
901 | 2-[(4-{2-ACETYLAMINO-2-[4-(1-CARBOXY- 3-METHYLSULFANYL-PROPYLCARBAMOYL)- BUTYLCARBAMOYL]-ETHYL}-2-ETHYL- PHENYL)-OXALYL-AMINO]-BENZOIC ACID | A | 1NZ7 | 0.71 | |
AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 2RDD | 0.77 | |
AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A,B,C,D | 1NX9 | 0.77 | |
AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 1H8S | 0.77 | |
AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 2EX6 | 0.77 | |
0E4 | N-acetyl-L-tyrosyl-L-valyl-L-alanyl- L-aspartic acid | B,D | 3GJS | 0.76 | |
B1L | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-HYDROXYBENZOATE | A | 1REJ | 0.7 | |
629 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL- PIPERIDIN-2-YL)- ACETIC ACID | A | 1JIJ | 0.71 | |
ABY | N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)- L-CYSTEINYLGLYCINE | A,B | 1PL2 | 0.75 | |
ABY | N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)- L-CYSTEINYLGLYCINE | A,B | 1PL1 | 0.75 | |
CEH | 5-{3-(S)-(4-(R)-ACETYLAMINO-4-CARBOXY- BUTYRYLAMINO)-3-[1-(R)-(1-(R)-CARBOXY- ETHYLCARBAMOYL)-ETHYLCARBAMOYL]- PROPYL}-2-(CARBOXY-PHENYLACETYLAMINO- METHYL)-3,6-DIHYDRO-2H-[1,3]THIAZINE- 4-CARBOXYLIC ACID | A | 1HVB | 0.78 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.78 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 2H5Q | 0.75 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XQM | 0.75 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLG | 0.75 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XA9 | 0.75 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.71 | |
485 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO- PYRAN-2-YL)- ACETIC ACID | A | 1JIL | 0.71 |